Today's Top Stories | | By The Associated Press | July 30, 2025 07:37 AM |
| | | By The Associated Press | July 30, 2025 07:24 AM |
| | By The Associated Press | July 30, 2025 04:48 AM |
| | | By The Associated Press | July 30, 2025 12:04 AM |
| | By Sam Quirke | July 29, 2025 10:42 AM |
|
|
Analysts' Upgrades | AON (NYSE:AON) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $426.00 price target on the stock, up previously from $400.00. This represents a 19.1% upside from the current price of $357.71. | Ares Capital (NASDAQ:ARCC) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $23.50 price target on the stock, up previously from $22.50. This represents a 2.6% upside from the current price of $22.91. | Brown & Brown (NYSE:BRO) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $130.00 price target on the stock, up previously from $126.00. This represents a 40.3% upside from the current price of $92.69. | Ecolab (NYSE:ECL) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $300.00 price target on the stock, up previously from $273.00. This represents a 13.5% upside from the current price of $264.31. | Heineken (OTCMKTS:HEINY) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating.The current price is $41.46. | Ormat Technologies (NYSE:ORA) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $103.00 price target on the stock, up previously from $87.00. This represents a 15.1% upside from the current price of $89.50. | The PNC Financial Services Group (NYSE:PNC) was upgraded by analysts at Oppenheimer Holdings, Inc. from a "market perform" rating to an "outperform" rating. They now have a $238.00 price target on the stock. This represents a 21.9% upside from the current price of $195.23. | Peloton Interactive (NASDAQ:PTON) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $11.00 price target on the stock, up previously from $7.50. This represents a 59.4% upside from the current price of $6.90. | Rapt Therapeutics (NASDAQ:RAPT) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $14.00 price target on the stock. This represents a 18.4% upside from the current price of $11.83. | Spotify Technology (NYSE:SPOT) was upgraded by analysts at DZ Bank AG from a "sell" rating to a "hold" rating. They now have a $652.00 price target on the stock. This represents a 1.7% upside from the current price of $641.06. | Seagate Technology (NASDAQ:STX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $175.00 price target on the stock. This represents a 19.9% upside from the current price of $145.99. | Supernus Pharmaceuticals (NASDAQ:SUPN) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $42.00 price target on the stock. This represents a 21.9% upside from the current price of $34.46. | TPG (NASDAQ:TPG) was upgraded by analysts at BNP Paribas Exane from a "neutral" rating to an "outperform" rating. They now have a $69.00 price target on the stock. This represents a 16.7% upside from the current price of $59.14. | Exagen (NASDAQ:XGN) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $12.00 price target on the stock. This represents a 33.2% upside from the current price of $9.01. |
| View More Upgrades
|
Analysts' Downgrades | Advanced Micro Devices (NASDAQ:AMD) was downgraded by analysts at DZ Bank AG from a "buy" rating to a "sell" rating. They now have a $150.00 price target on the stock. This represents a 16.1% downside from the current price of $178.69. | American Tower (NYSE:AMT) was downgraded by analysts at HSBC Holdings plc from a "buy" rating to a "hold" rating. They now have a $235.00 price target on the stock. This represents a 10.2% upside from the current price of $213.33. | NOV (NYSE:NOV) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $15.00 price target on the stock, down previously from $17.00. This represents a 16.3% upside from the current price of $12.89. |
| View More Downgrades
|
Analysts' New Coverage | Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Raymond James Financial, Inc.. They set an "outperform" rating and a $370.00 price target on the stock. This represents a 8.8% upside from the current price of $340.05. | Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $17.00 price target on the stock. This represents a 81.4% upside from the current price of $9.37. | BridgeBio Pharma (NASDAQ:BBIO) is now covered by analysts at Raymond James Financial, Inc.. They set an "outperform" rating and a $56.00 price target on the stock. This represents a 20.9% upside from the current price of $46.32. | Corbus Pharmaceuticals (NASDAQ:CRBP) is now covered by analysts at B. Riley. They set a "buy" rating and a $28.00 price target on the stock. This represents a 198.2% upside from the current price of $9.39. | Cytokinetics (NASDAQ:CYTK) is now covered by analysts at Raymond James Financial, Inc.. They set a "market perform" rating on the stock.The current price is $36.17. | Journey Medical (NASDAQ:DERM) is now covered by analysts at B. Riley. They set a "buy" rating and a $12.00 price target on the stock. This represents a 54.2% upside from the current price of $7.78. | Edgewise Therapeutics (NASDAQ:EWTX) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating and a $46.00 price target on the stock. This represents a 221.0% upside from the current price of $14.33. | National Vision (NASDAQ:EYE) is now covered by analysts at Roth Capital. They set a "buy" rating and a $36.00 price target on the stock. This represents a 44.5% upside from the current price of $24.92. | Kymera Therapeutics (NASDAQ:KYMR) is now covered by analysts at B. Riley. They set a "buy" rating and a $60.00 price target on the stock. This represents a 35.6% upside from the current price of $44.24. | Scholar Rock (NASDAQ:SRRK) is now covered by analysts at Raymond James Financial, Inc.. They set a "strong-buy" rating and a $53.00 price target on the stock. This represents a 36.5% upside from the current price of $38.82. |
| View More New Coverage
|
Calendars from MarketBeat | |
|
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
|
0 Response to "🌎 Advanced Micro Devices Downgraded, AON Upgraded, Brown & Brown Upgraded and more..."
Post a Comment